November 3, 2021
Timber Pharmaceuticals Announces Proposed Public Offering
Basking Ridge, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE…
Pharmaceuticals, Biotechnology and Life Sciences
Basking Ridge, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE…
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its…
Libervant™ (diazepam) Buccal Film continues to progress through the FDA review process in advance of PDUFA goal date of December…
BOSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives…
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. On-going Phase 2b clinical trial (ASPEN-COVID-19) evaluating rNAPc2 as…
SANTA MONICA, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a company advancing medicines to…
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company,…
Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates…
Company to host conference and webcast on November 12, 2021 at 9:00 am ET / 6:00 am PTBURLINGAME, Calif., Nov.…
MELBOURNE, Australia, Nov. 01, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the…